- Exploiting cellular pathways to develop new treatment strategies for AMLAmir T Fathi
Division of Hematologic Malignancies, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, 1650 Orleans Street, Baltimore, MD 21231, USA
Cancer Treat Rev 36:142-50. 2010..In this review, we aim to provide a summary of the preclinical and clinical investigations of selected promising agents currently under study...
- Chemotherapy for advanced stage non-small cell lung cancerAmir T Fathi
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231 1000, USA
Semin Thorac Cardiovasc Surg 20:210-6. 2008..Clinical trials have also recently demonstrated increased efficacy for agents such as docetaxel and pemetrexed in the second line setting for refractory disease...
- New agents in acute myeloid leukemia: beyond cytarabine and anthracyclinesAmir T Fathi
Division of Hematologic Malignancies, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, 1650 Orleans Street, CRB 1 Room 289, Baltimore, MD 21231, USA
Curr Oncol Rep 11:346-52. 2009....